<DOC>
	<DOC>NCT01164540</DOC>
	<brief_summary>This study evaluates whether treatment with rosuvastatin on top of standard anti-coagulant treatment will decrease the risk of recurrent venous thromboembolism and arterial thromboembolic events in patients with previous deep vein thrombosis or pulmonary embolism.</brief_summary>
	<brief_title>Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Signed informed Consent. Patients with venous thromboembolism who are treated with anticoagulant according to the current guidelines Patients in need of or already treated with lipid lowering drugs Active liver or kidney disease or dysfunction or muscle disorders Unstable medical or psychological condition that interferes with study participation Pregnant woman or woman with childbearing potential who are not willing to use contraception History of statinrelated muscular pain, or hypersensitivity to statins</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Deep venous thrombosis</keyword>
	<keyword>Pulmonary embolism</keyword>
	<keyword>rosuvastatin treatment</keyword>
</DOC>